Bridgepoint Group (LON:BPT) Sets New 12-Month Low – Should You Sell?

Bridgepoint Group plc (LON:BPT)’s share price hit a new 52-week low during mid-day trading on Monday . The stock traded as low as GBX 218.40 and last traded at GBX 218.40, with a volume of 7927679 shares trading hands. The stock had previously closed at GBX 226.60.

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. boosted their price target on shares of Bridgepoint Group from GBX 395 to GBX 415 and gave the stock a “buy” rating in a research note on Monday, January 5th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of GBX 385.

Bridgepoint Group Price Performance

The business has a fifty day moving average price of GBX 260.19 and a 200-day moving average price of GBX 284.26. The company has a current ratio of 279.03, a quick ratio of 3.60 and a debt-to-equity ratio of 55.04. The stock has a market capitalization of £1.91 billion, a PE ratio of 41.03, a PEG ratio of 0.61 and a beta of 1.43.

Bridgepoint Group (LON:BPT) last announced its quarterly earnings data on Thursday, March 12th. The company reported GBX 26.50 earnings per share for the quarter. Bridgepoint Group had a return on equity of 4.25% and a net margin of 7.68%. Research analysts expect that Bridgepoint Group plc will post 17.4062165 EPS for the current fiscal year.

Insider Buying and Selling

In other Bridgepoint Group news, insider Michelle Scrimgeour acquired 21,616 shares of the stock in a transaction dated Thursday, March 12th. The stock was purchased at an average cost of GBX 230 per share, for a total transaction of £49,716.80. 0.60% of the stock is owned by insiders.

About Bridgepoint Group

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.